By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Synergy Pharmaceuticals 

6334 Winfield Boulevard

Margate  Florida  33063  U.S.A.
Phone: 954-801-3950 Fax: n/a


SEARCH JOBS


Industry
Pharmaceutical






Company News
Synergy Pharmaceuticals To Present Additional Positive Phase 2b Study Results For Plecanatide In Patients With Irritable Bowel Syndrome With Constipation At American College of Gastroenterology 2014 Annual Scientific Meeting 10/7/2014 10:51:14 AM
Synergy Pharmaceuticals Reaches Halfway Mark For Second Pivotal Phase 3 Trial Of Plecanatide In Patients With Chronic Idiopathic Constipation 9/18/2014 10:10:15 AM
Synergy Pharmaceuticals Reports Second Quarter And First Half 2014 Financial Results 8/12/2014 8:35:41 AM
Synergy Pharmaceuticals To Present At Canaccord Genuity Growth Conference 8/6/2014 9:19:59 AM
Synergy Pharmaceuticals Completes Patient Enrollment For Its SP-333 Phase 2 Trial In Patients With Opioid-Induced Constipation 7/17/2014 10:56:29 AM
Synergy Pharmaceuticals Reaches Halfway Mark For The First Pivotal Phase 3 Trial Of Plecanatide In Patients With Chronic Idiopathic Constipation 7/14/2014 11:29:06 AM
Synergy Pharmaceuticals Announces Successful End-Of-Phase 2 Meeting With FDA For Plecanatide In Irritable Bowel Syndrome With Constipation 7/8/2014 10:50:18 AM
Synergy Pharmaceuticals Appoints Paul Eng, Ph.D., As Senior Vice President, Drug Development 5/29/2014 7:31:40 AM
Synergy Pharmaceuticals’ Chairman And CEO, Dr. Gary S. Jacob, Awarded Honorary Degree By The University of Missouri – St. Louis 5/15/2014 9:19:18 AM
Synergy Pharmaceuticals To Present At 2014 UBS Global Healthcare Conference 5/14/2014 7:13:39 AM
12345678910...
//-->